Brief: Gritstone Announces Updated Overall Survival Results In Advanced Colorectal Cancer Patients From Phase 1/2 Study Of Granite And Trial In Progress Poster At ASCO
May 31 (Reuters) - Gritstone bio Inc GRTS.O :
* GRITSTONE ANNOUNCES UPDATED OVERALL SURVIVAL RESULTS IN
ADVANCED
COLORECTAL CANCER PATIENTS FROM PHASE 1/2 STUDY OF GRANITE AND
TRIAL IN PROGRESS POSTER AT ASCO
* GRITSTONE BIO- OS FOR PATIENTS WITH MSS-CRC WHO HAD TWO
PRIOR
LINES OF THERAPY AND MOLECULAR RESPONSE AS PRESENTED AT ESMO
2021, TO EXCEED 18 MONTHS
Source text for Eikon: ID:nGNXbc9t0D
Further company coverage: GRTS.O
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy